Board of Directors & Charter
Committees of the Board & Charters
> Board of Directors Charter
As a corporately driven organization, the MedTech Board of Directors is comprised of senior officers of the manufacturing companies:
Daniel Jonas
Chairman, Director, Board of Directors
Jonas, a founding member of MedTech and Board member since 2004, joined ConMed Corporation as General Counsel in August 1998 and became the Vice President-Legal Affairs in March 1999. In September 1999 through July 2005, Jonas assumed responsibility for some of ConMed’s Regulatory Affairs and Quality Assurance departments. In March 2003, he also became responsible for the administration of ConMed’s ethics policy. In addition to his duty as secretary of the MedTech Board of Directors, Jonas also serves as co-chair of the Issues, Events & Services committee.
Amy Ryan
Treasurer, Director, Board of Directors
After her 16-year tenure with InfiMed Inc., Ryan was appointed as President in October 2007. Prior to her appointment, Ryan honed leadership experience as Executive Vice President of the company. With expertise in operations development, engineering, marketing and P&L management, Ryan looks to strengthen InfiMed’s trusted commitment to high quality products, global service, and innovative solutions to challenges. As a director, Ryan’s mission is to continue to enhance MedTech’s support for local companies who are bringing innovation to a globalizing medical technologies field.
Director, Borad of Directors
Marty now serves as Corporate Vice President of Moog, Inc Medical Devices Group. Marty joined Moog in 1980, and has worked in all the company's groups, spending the first half of his career in the Aerospace areas: Space Systems, Missile Systems, and Aircraft, then transitioning to the Industrial Group in the early 1990!s. Prior to becoming a Corporate Vice President, Marty was General Manager at the Moog facility located in Stuttgart, Germany for three years. Marty is currently responsible for the newest operating segment of Moog in the Medical Devices Market. He earned his Bachelor degree from Canisius College and his M.B.A. in Finance from St. Bonaventure University.
Paul Buckley
Director, Board of Directors
Buckley has been president of Applied Sciences Group since 1997, serving in engineering, operations management and strategic development areas. He has a bachelor's degree in biomedical engineering and a master’s degree in systems engineering from RPI. Prior to his employment at ASG, Buckley worked in the aerospace and telecommunications industries in various engineering and management capacities. He currently chairs the University at Buffalo's Center for Entrepreneurial Leadership (CEL) Alumni Association and is the 2004 CEL Taylor Kew award recipient for entrepreneurial excellence. Buckley is a board member of the Buffalo Niagara Partnership, the UB School of Medicine's Dean's Council, and the Buffalo branch of the American Diabetes Association.
Director, Board of Directors
John is partner with the intellectual property law firm Heslin Rothenberg Farley & Mesiti. He graduated cum laude from Syracuse University College of Law. Mr. Boger also received cum laude, a Bachelor of Science degree in Biomedical Engineering from Syracuse University and a Master of Science degree in Biomedical Engineering from the University of Utah. Previous to joining Heslin Rothenberg Farley & Mesiti P.C. Mr. Boger was Senior Counsel to Capital District Physicians' Health Plan, Inc. Prior to attending law school, Mr. Boger worked for 8 years at DePuy, Inc. as a product development engineer and product manager specializing in orthopaedic implant design.
Dave Eilers
Director, Board of Directors
Throughout his twenty-five year career, Dave Eilers has been a goal-oriented enterprise leader who enjoys pioneering new products as well as opening new markets worldwide. Mr. Eilers has experience with Consumer Goods such as leading the introduction and roll-out of Personal Pan Pizza for Pizza Hut and opening new markets for Hathaway Division of Warnaco. His experience in Durable Goods is as diverse as —home satellite dishes and commercial chinaware for Syracuse China/ Libbey Foodservice. For the last decade, Dave has been employed in the Healthcare Industry working both as a consultant and in management for two private-equity investors before the ten-company group was acquired in March of 2006. Mr. Eilers’ current interest is applying an Open Innovation business model to Diagnostic Healthcare-- bridging the gap between invention and market introduction. Dave was one of three founders of Blue Highway LLC, an advanced R&D subsidiary of Welch Allyn. Blue Highway is dedicated to creating innovative, intellectual capital through early detection and diagnosis of adverse health conditions, aggregation of data to enhance clinical outcomes, and comprehensive, clinical decision support. In the course of his business development activities, Mr. Eilers has observed a variety of clinical procedures at many prestigious teaching institutions such as Brigham & Women’s Hospital, Mayo Clinic, Harvard Medical School and Cleveland Clinic.
Ben Harp
Director, Board of Directors
Harp joined Polymer Conversions Inc. in December 2003 as the Director of Business Development. In June 2004 he became the Chief Operating Officer. He holds a Masters of Business Administration and a Bachelors of Science in Mathematics from Canisius College. He currently is the Vice Chair of the Life Science Council of the Buffalo Niagara Partnership and is on the board of directors for Manufacturers Association of Plastics Processors. Harp previously served on the board of directors for the Society of Plastics Industry from 2004 to 2007.
Holly Hillberg
Director, Board of Directors
Hillberg currently serves as Vice President of Research & Development at Ortho Clinical Diagnostics, a Johnson & Johnson company. In this role, she is responsible for the pipeline delivery of products to the marketplace and sits on the Ortho Clinical Diagnostics Board. Hillberg spent 23 years at Eastman Kodak, holding executive positions in R&D, Engineering, Operations and Global Commercialization and led the divestiture of Eastman Kodak Company’s Health Imaging Group business to the Onex Corporation, which led to the creation of Carestream Health, Inc.
Most recently, she was Vice President and Chief Technology Officer with Carestream Health where she served on MedTech’s board from 2008-2010. In 2009, Hillberg received the Rochester Business Alliance Women’s Council’s annual Athena Award, honoring an outstanding professional woman who demonstrates exceptional levels of business accomplishment and community involvement.
Secretary, Director, Board of Directors
Holly is a partner at Hiscock & Barclay, LLP in the Business Services group. Her practice focuses on corporate and commercial contracts and transactions, especially relating to intellectual property licensing and health care. She also concentrates on ethics and corporate compliance, including fraud & abuse counseling relative to the marketing of drugs and devices. Prior to joining the firm in 2005, she served as assistant general counsel at Taro Pharmaceuticals, a publicly traded pharmaceutical manufacturer, where she designed, developed and implemented a worldwide ethics and corporate compliance program and served as chair of Taro compliance committee. Ms. Hoehner holds a B.S. from Cornell University and a J.D. from Columbia Law School.
Bruce Kirk 
Director, Board of Directors
Bruce D. Kirk is responsible for the advancement of Innovation Effectiveness throughout the corporation. His responsibilities include innovation process development and deployment, employee education and training, global benchmarking, next generation process development and the implementation of the Innovation Black Belt role across Corning. He is the corporate process owner of Corning’s Five Stage Innovation Process and the Roadmapping process. Bruce led the Revitalize Innovation Globally (RIG) initiative for the Corporation since 2005. Previously, he led the innovation process portion of Corning Competes re-engineering from 1995 to 1997.
His focus was on Innovation Project Management and its deployment in Corning’s faster new product and process R&D environment during the telecom growth period. Bruce has extensive experience teaching the principles and practice of the innovation process to teams in Corning’s worldwide network. He is also skilled in facilitating the development of roadmaps and business technology strategies with the business units. Bruce joined Corning in 1976 and has held various leadership positions in sales, sales management, marketing management and business management. His career experience has spanned several Corning divisions including Medical Products, Science Products, Human Resources, Photonic Technologies, and Science and Technology. Bruce holds a bachelor’s degree in business finance from Susquehanna University.
Doug Linquest
Director, Board of Directors
Doug Linquest leads Welch Allyn’s Global Product Marketing and Clinical Affairs Organization. In this capacity, he is responsible for developing and maintaining a strategically-aligned, integrated roadmap encompassing medical devices, disposables, software applications and related services across Welch Allyn’s focused segments. In addition, he manages product margins and end-of-life strategies across the category portfolio, ensuring that the customer requirements in Welch Allyn’s focused care settings and geographies are delivered via new product solutions. Linquest also provides good clinical practice expertise to the new product development process, and contributes to development and execution of category growth plans, including acquisition and partnership elements, to support Welch Allyn’s operating plan. A native of Skaneateles, NY, Linquest started his career at Welch Allyn in 1983 and has worked in a variety of sales, marketing, and executive leadership roles. He holds a B.A. in English from Colgate University and an M.B.A. from Syracuse University.
Director, Board of Directors
In her current role, Tracy MacNeal is Corporate Director of Business Development for ATW Companies and is responsible for the expansion of strategic licensing and manufacturing relationships. Her background includes new product launches in pharmaceuticals with Merck and consulting for several startups in cosmetics and sterile injectables.
Director, Board of Directors
Bill Maggio is the president and CEO of IMMCO diagnostics, Inc. a global manufacturer of autoimmune and esoteric diagnostics. Prior to joining IMMCO, Bill held senior level Business Development and operational positions at Boehringer Mannheim, Roche, and Bureau VERITAS. He has extensive business experience in Europe and Asia having and currently serves on a number of not for profit boards, including the Canisius College Board of Trustees, the University at Buffalo center for Advanced Biomedical and Bioengineering Technology Board of Advisors, and the West Side Rowing Club Board of Directors.
Harold Meckler
Director, Board of Directors
Since 2000, Dr. Meckler has led AMRI's Science & Technology department. This group helps to manage the AMRI IP portfolio, internal research projects, Scientific Information systems and the AMRI sample collection. Dr. Meckler joined AMRI in 1995 to head up the Chemical Development and cGMP Production Groups. Prior to that he worked at Telor Ophthalmic Pharmaceuticals (Wilmington, Massachusetts) and built their Organic Chemistry Department. In 1984, Dr. Meckler joined the Chemical Development Group of the CIBA Pharmaceuticals Division (Summit, New Jersey) where he focused on the process development, pilot plant scale up and cGMP production of a wide variety of compounds. Prior to that, Dr. Meckler worked in the Chemical Development Group of Sterling Winthrop (Rensselaer, New York). Dr. Meckler earned his Ph.D. in 1983 from the State University of New York at Buffalo. He is a member of the Editorial Advisory Board of Organic Process Research and Development.
Bob Ruppenthal
Director, Board of Directors
For nearly thirty years, Ruppenthal has led RTEmd in strategic direction, business development and administration. His company is focused on development and testing of software for regulated medical devices in clinical diagnostics, medical imaging and information systems. Before founding RTEmd, Ruppenthal was a practicing electrical engineer designing hardware and software for complex systems in aerospace and medical applications.
Scott Steele
Director, Board of Directors
Scott Steele joined the University of Rochester in December of 2008 and currently serves as the Director of Research Alliances. In this role he fosters strategic research partnerships between the University and industry, government agencies, and other academic institutions. He is actively involved with the University of Rochester Clinical and Translational Science Institute, serving as the Director of the Public-Private Partnerships Key Function. Additionally, he holds an adjunct appointment in the Department of Community and Preventive Medicine in the School of Medicine and Dentistry. Dr. Steele received his BS with Honors in Biology from Union College in Schenectady, NY. Following this, he performed research at the General Electric Center for Research and Development and was a fellow at the National Institutes of Health in Bethesda, MD. Dr. Steele completed his MA and PhD in Molecular Biology at Princeton University.
Committee Structure and Chairs
MedTech's Committees of the Board help to further the success of the organization through guiding and supporting the organizations strategy and daily activities. Committee chairs are drawn from the membership:
Issues, Events & Services:
> John Boger, Heslin Rothenberg Farley & Mesiti (Co-chair)
> Dave Eilers, Blue Highway (Co-chair)
> Issues Events & Services Charter
Marketing & Membership Development:
> Bob Ruppenthal, RTEmd (Chair)
> Marketing & Membership Development Charter
Science & Technology:
> Ted Farrell, Ortho Clinical Diagnostics (Chair)
> Science &Technology Charter
Government & Public Affairs:
> Chris Knospe, Greatbatch Medical (Chair)
> Governance & Public Affairs Charter
Finance:
> Amy Ryan, InfiMed (Chair)
> Finance Charter
Governance & Nominating:
> Holly Hoehner, Hiscock & Barclay (Chair)
> Governance & Nominating Charter